Scientists are turning to an unlikely source in the search for the next generation of weight-loss drugs: pythons. New research highlighted in a recent Yahoo News report suggests that molecules found in python blood could help develop safer and more effective treatments for obesity.
Pythons are known for their extreme feeding habits—they can consume prey as large as their own body weight and then go months without eating. During this period, their metabolism undergoes dramatic changes. Researchers studying these reptiles discovered that after feeding, certain molecules in their blood surge significantly, helping regulate appetite and energy use.
One molecule in particular, called pTOS (para-tyramine-O-sulfate), has drawn attention. It is produced by gut bacteria and spikes more than 1,000-fold after a python eats. When scientists tested this compound on obese mice, the animals ate less and lost around 9% of their body weight within a month—without major side effects.
This discovery is especially important because current popular weight-loss drugs, such as GLP-1 receptor agonists, can cause nausea, muscle loss, and other gastrointestinal issues. In contrast, pTOS appears to work directly on the brain’s appetite-control center—the hypothalamus—potentially avoiding many of these drawbacks.
Also Read: Sapodilla (Chikoo): Nutrition, Health Benefits, and Uses
Researchers say this approach follows a proven path: earlier blockbuster drugs like Ozempic were inspired by compounds found in reptile venom. Now, python biology could open the door to a new class of treatments that suppress appetite more naturally and with fewer side effects.
While the findings are promising, experts caution that more research and human trials are needed before such treatments become widely available.
Also Read: Weight loss article
